Acumen Pharmaceuticals (ABOS)

• Market cap: $139M
• 1 day: 4.09%
• 5 days: 16.84%
• 1 month: 44.94%
• 3 months: 56.85%
• 6 months: 122.33%
• Year to date: 23.78%
• 1 year: -20.76%
• 5 years: -88.61%
• 10 years: -88.61%
• Sector: Healthcare
• Industry: Biotechnology

About: Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Employees: 52